Stephen J. Laughton

Buccal swabs and treated cards: methodological considerations for molecular epidemiologic studies examining pediatric populations.

R. Cohn, E. Milne, S. Beckett, 2008, American journal of epidemiology.

Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor

S. Kaste, K. Wright, A. Gajjar, 2017, Oncotarget.

Imatinib Mesylate–Induced Pseudoporphyria in Two Children

Stephen J. Laughton, D. Purvis, C. Mahon, 2014, Pediatric dermatology.

Mitotane in the treatment of childhood adrenocortical carcinoma: a potent endocrine disruptor

Stephen J. Laughton, P. Hofman, C. Jefferies, 2018, Endocrinology, diabetes & metabolism case reports.

Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia.

M. Haber, M. Norris, Stephen J. Laughton, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group

David T. W. Jones, J. Olson, M. Kool, 2013, Acta Neuropathologica.

Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.

T. Merchant, C. Sklar, A. Gajjar, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Malignant Melanoma in Children and Adolescents Treated in Pediatric Oncology Centers: An Australian and New Zealand Children’s Oncology Group (ANZCHOG) Study

N. Gottardo, F. Alvaro, J. Hansford, 2021, Frontiers in Oncology.